Akemi Suyama-Kagitani

Statistics

Publications

Citations

542

H-Index

Active since

2010

Affiliations

GlaxoSmithKline (United States)(Current)

Shionogi (Japan)

Research Triangle Park Foundation

Futaba (Japan)

Akemi Suyama-Kagitani is an author at GlaxoSmithKline (United States) specializing in antiviral drug resistance, antiviral resistance, and life sciences.

Publications per year

2010–2018

Publications

<i>In Vitro</i>Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor

Masanori Kobayashi, Tomokazu Yoshinaga, Takahiro Seki et al. · Antimicrobial Agents and Chemotherapy · 2010 · 377 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17

Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection

Tomokazu Yoshinaga, Masanori Kobayashi, Takahiro Seki et al. · Antimicrobial Agents and Chemotherapy · 2014 · 100 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17

Effects of Raltegravir or Elvitegravir Resistance Signature Mutations on the Barrier to Dolutegravir Resistance <i>In Vitro</i>

Takahiro Seki, Akemi Suyama-Kagitani, Shinobu Kawauchi-Miki et al. · Antimicrobial Agents and Chemotherapy · 2015 · 41 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Novel secondary mutations C56S and G149A confer resistance to HIV-1 integrase strand transfer inhibitors

Tomokazu Yoshinaga, Takahiro Seki, Shigeru Miki et al. · Antiviral Research · 2018 · 24 citations

Life Sciences, Molecular Biology, Molecular Genetics +11

1–4 of 4